EvoNexus

Snell & Wilmer Partner Roger Rappoport led an insightful seminar titled, ''Startup Fundamentals: Understanding the ‘Terms’ in Term Sheets.'' This event marked the last of three workshops tailored to startup founders, executives, entrepreneurs, innovators, and developers. Snell & Wilmer is proud to collaborate with Access Silicon Valley and EvoNexus to support this series and help startup leaders navigate the unique challenges of early growth. Stay tuned for more from this valuable series. #Startups #Entrepreneurship #Technology

Snell & Wilmer along with EvoNexus were thrilled to co-host the Access Silicon Valley Startup Fundamentals 3 Term Sheet workshop presented by my colleague and startup expert Roger Rappoport at our new San Diego office. This informative session included a deep dive into term sheets and related topics such as when and from whom to take money, when is an amount raised too much or too little, and the perils of both, the anatomy of a term sheet, and the impact of term sheets on existing shareholders. Also discussed were the most recent trends relating to: liquidation preferences, participation rights, anti-dilution provisions, pay-to-play provisions, redemption rights, registration rights, rights of first refusal, drag along rights, co-sale rights, among others. A fantastic and engaging event that was enjoyed by an engaged gathering of founders and startup veterans!! Stay tuned for our next event!!

Our partnership with Saudi Public Investment Fund (PIF) company, Alat will help us to further extend the reach of EvoNexus and provide our portfolio companies opportunities at a global level.

🎤 Today we announced the discovery of a novel cryptic human proteome and $4M pre-seed financing! To learn more, see our press release below. 😯 We discovered more than 8,000 previously unidentified peptides on the surface of cells. About 1,000 of these appear to be specific to cancer cells making them ideal therapeutic targets! ❤️🩹👩⚕️ The funds will be used to develop first-in-class cancer immunotherapies towards these druggable "dark" therapeutic targets 💉 Special thanks to our fantastic investors Genedant Capital, SeaX Ventures, SOSV, Swell VC, Phase Two Ventures, and WS Investments as well as our awesome angels! Also, a shoutout to Oregon Health & Science University, IndieBio, EvoNexus, and Nucleate for their support. We also appreciate the coverage by The Wall Street Journal, Fortune and Endpoints News in their newsletters! 🙏 Corey Dambacher, Imad Ajjawi, PhD, MBA, Ashley Woodfin, Alex Jaeger, Kerry Wilson, Joseph Estabrook, Jessica Weir #darkgenome #cancerimmunotherapies #drugdiscovery #darkproteome #immunotherapies https://lnkd.in/g5aCuWzt

Google’s Head of Emerging AI Partners (recently retired) and AIR investor Geneva Lake stopped in to Frontwave Arena last Friday to see AIR autotracking in action. Our first live test went well, with an AIR One robot following the game up and down the court with little human supervision. We’ll be sharing results from our next test later this month. Stay tuned. AIR will ultimately offer networked camera robots that function as a hive mind and give crews new tools to augment or automate live production. Camera operators will conduct teams of inexpensive robots to better tell their story and capture more and better content. And just like with our current robots, these camera operators can be onsite or hundreds of miles away. If you’d like a live demo or eval of the AIR platform, get in touch here or with an AIR reseller today. Broadfield Distributing Inc Key Code Media Kevin McClave Nick Nordquist San Diego Clippers Texas Legends NBA G League #StarWarsNight #Remi #remoteproduction San Diego Pride NuFund Venture Group EvoNexus

Sensoride was admitted to EvoNexus as a two man team in 2022. During that time, the startup focused on developing software algorithms that would significantly enhance the performance of radar sensors in a variety of use cases. Throughout their development, they received hands-on mentoring, collaboration, strategic connections, and facilities support from our unique non-profit incubator. I'm extremely pleased that long-time corporate partner Murata will be the new home of Sensoride.

Thrilled to share that Sensoride, a trailblazer in RADAR sensor technology for autonomous driving, has joined forces with Murata. Congratulations Daniel Moradi, Sensoride Team, Murata and EvoNexus. https://lnkd.in/g9_BEBWP #AutonomousDriving #RADARTechnology #Innovation #Teamwork

Thermal imaging pioneer, Dr. William Perrish describes Obsidian Sensors' technology as "the biggest innovation since the invention of the microbolometer." Historically thermal imaging systems have been expensive and initially only used by the military. Obsidian has developed a manufacturing process that enables the creation of their thermal sensors at 1/10 the cost of current providers. Thermal imaging cameras with Obsidian's technology one day may be standard equipment on automobiles, like radars and cameras. Imagine a pedestrian or animal crossing the street in front of your car, unseen by your headlights. Thermal image sensors provide a new level of information for the vehicle and driver.

EvoNexus is fortunate to have the global brands of LG and Qualcomm associated with our unique non-profit technology incubator. Their involvement attracts high-quality startups to our program and often accelerates their time to market. EvoNexus Board Members exemplify the importance of supporting the early-stage innovation ecosystem. https://lnkd.in/eVAJSujJ

Thank you to our incredible moderator, Noel Gillespie of Procopio, Cory, Hargreaves & Savitch LLP for hosting the MDs on the Front Line SIG last week. Our panel consisting of Dr. James Killeen of UC San Diego Health, Dr. Saul Levine of Sharp HealthCare, and Dr. Ian Reilly of Scripps Health gave the audience invaluable insights into the past, present, and future of healthcare technology helping the ER. Thank you again to all involved and to our community for asking incredible and insightful questions at this event. See you at the next one! 🚀